financetom
Business
financetom
/
Business
/
Praana Group Completes Acquisition of Multi-Chem Business
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Praana Group Completes Acquisition of Multi-Chem Business
May 4, 2026 5:15 AM

MUMBAI, India, May 4, 2026 /PRNewswire/ -- Praana Group today announced the completion of its acquisition of Multi-Chem, now operating as Sterling MultiChem within the Sterling Specialty Chemicals platform. The acquisition strengthens Praana Group's specialty chemicals platform and expands its energy-sector capabilities.

The combination brings together Sterling Specialty Chemicals' expertise in specialty chemical manufacturing, polymer technologies, and advanced surfactant systems with Multi-Chem's field service capabilities, enhancing its ability to support oil and gas operators with high-performance chemical solutions and technical expertise across upstream, midstream, and downstream operations.

Multi-Chem has built a strong presence in the oilfield chemicals sector through application-driven programs designed to address complex operational and production challenges. Its solutions support operators across the energy value chain, including chemicals used in drilling, completion, and production, as well as programs focused on flow assurance, corrosion and scale management, water treatment, and process optimization. These capabilities help maintain asset integrity and improve operational performance across energy assets.

"This acquisition aligns with Praana Group's long-term strategy of strengthening its global specialty chemicals platform through technology leadership, manufacturing excellence, and strong customer partnerships," said Vishal Goenka, Vice Chairman of Praana Group. "Multi-Chem has developed a strong reputation for delivering high-performance oilfield chemical solutions and field expertise across complex operating environments. By combining Multi-Chem's field-driven solutions supporting upstream drilling, completion and production operations, as well as midstream flow assurance and downstream process and asset integrity programs, with Sterling Specialty Chemicals' manufacturing scale and specialty chemistry capabilities, we will expand our geographic reach and strengthen our ability to deliver high-value solutions across the energy sector."

Customers will benefit from an expanded portfolio of specialty chemical technologies, stronger technical support, and deeper application expertise. Both organizations share a strong commitment to safety, operational excellence, and reliable solutions that help customers maintain efficiency and performance in demanding operating environments.

Sterling Specialty Chemicals will maintain operational continuity for Sterling MultiChem as integration progresses. Both teams will continue supporting customers and operations while leadership identifies opportunities for technology development, operational synergies, and long-term growth.

About Praana Group

Praana Group is a diversified multinational business group in specialty chemicals and advanced materials. Its portfolio includes Galata Chemicals, Artek Surfin Chemicals, Sterling Specialty Chemicals, Sterling Multichem, and 3B Fibreglass. Praana continues to expand its global capabilities through strategic acquisitions and investments across specialty chemicals and advanced materials.

Contact

India Corporate Office

Deepa Viswanath

[email protected] 

US

Sydney Rickett

[email protected] 

Photo: https://mma.prnewswire.com/media/2971715/Praana_Group_Sterling_Multichem.jpg

Logo: https://mma.prnewswire.com/media/2971716/Sterling_MultiChem_Logo.jpg

Logo: https://mma.prnewswire.com/media/2905114/PRAANA_Logo.jpg

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/praana-group-completes-acquisition-of-multi-chem-business-302761074.html

SOURCE Praana Group

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
OBOOK Shares Fall Pre-Bell After Nasdaq Listing
OBOOK Shares Fall Pre-Bell After Nasdaq Listing
Oct 17, 2025
09:27 AM EDT, 10/17/2025 (MT Newswires) -- OBOOK ( OWLS ) shares were down 38% in Friday premarket activity, continuing their losses after the company's Nasdaq listing on Thursday. The company's shares closed at $55.55 on Thursday, down 18% from their $68 per share opening price. The company said that at the closing price on Thursday its market capitalization was...
Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation
Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation
Oct 17, 2025
TORONTO, Oct. 17, 2025 /PRNewswire/ -- Visionary Holdings Inc. ( GV ) , a Nasdaq-listed enterprise, announced today that it has completed the equity adjustment of Sikang (Guangzhou) Health Industry Investment Co., Ltd. (hereinafter referred to as the Joint Venture Company), a joint venture established with Guangzhou Sikang Investment Holding Co., Ltd. (hereinafter referred to as Guangzhou Sikang), and officially...
Neurocrine Biosciences Says Late-Stage Movement Disorder Study Shows Ingrezza's Therapeutic Efficacy at Lowest Available Dose
Neurocrine Biosciences Says Late-Stage Movement Disorder Study Shows Ingrezza's Therapeutic Efficacy at Lowest Available Dose
Oct 17, 2025
09:29 AM EDT, 10/17/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Friday that a new post-hoc analysis of a late-stage study showed clinically meaningful improvements in tardive dyskinesia symptoms in patients treated with Ingrezza at the lowest available dose of 40 mg. The company said 90% of participants who received continuous treatment for 48 weeks improved by at...
AbbVie Closes Bretisilocin Acquisition
AbbVie Closes Bretisilocin Acquisition
Oct 17, 2025
09:28 AM EDT, 10/17/2025 (MT Newswires) -- AbbVie ( ABBV ) said Friday it has closed the acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate bretisilocin. Bretisilocin is a psychedelic compound in phase 2 clinical development for the treatment of patients with moderate to severe major depressive disorder, AbbVie ( ABBV ) said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved